Effectiveness and cost-effectiveness of Pain Rehabilitation Programs (PRP) for patients with chronic musculoskeletal pain: less is better?

Effectiveness and cost-effectiveness of Pain Rehabilitation Programs (PRP) for patients with chronic musculoskeletal pain: less is better? - Effectiveness of PRP: less is better?

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON36237

Enrollment

276

Registered

2011-08-18

Start date

2011-10-25

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic pain non-malignant pain

Interventions

The control intervention will be care as usual. The experimental intervention will not differ in content of PRP. The experimental group will receive PRP in 4 weeks less than care as usual.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients 1. are referred to the 12,16 or 20 weeks Pain Rehabiltiaton Program (PRP) at the UMCG, 2. have chronic musculoskeletal pain (CMP), 3. experience disability caused by CMP, 4. attend no other kinds of treatment, 5. are 18 years or older, 6. are willing to participate in the study, 7. WPN 3 and 4. Defined as:the social and psychosocial factors are complex and relevant regarding maintaining pain related disability.

Exclusion criteria

Exclusion criteria: Patients 1. are included for 8 weeks of PRP 2. are not willing to participate in the study, 3. are unable to understand the Dutch language, 4. have relevant comorbidities.

Design outcomes

Primary

Measure	Time frame
Pain related disability, measured with the Pain Disability Index, will be the main outcome.	—

Secondary

Measure	Time frame
For cost-effectiveness direct and indirect costs will be calculated.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)